08.08.16
The Natural and Non-prescription Health Products Directorate (NNHPD), of Health Canada, has concluded that HP Ingredients' application for its proprietary bergamot ingredient known as BERGAMONTE BPF "is in compliance pursuant to section 7 of the Natural Health Products Regulations (NHPR)," and has thus issued product license NPN #80068556 for BERGAMONTE BPF capsules.
Further, the following claims are now allowed to be made for Canadian Bergamonte products (500 mg):
BERGAMONTE BPF contains bioactive compounds of extract of the juice and albedo of citrus bergamia risso, standardized to > 30% polyphenolic flavonoids consisting of Naringin, Neohesperidin, Neoeriocitrin, 1% Melitidine, and 2% Brutelidine. These flavonoids are clinically proven to help maintain healthy cholesterol levels, healthy blood glucose level, and increase HDL-cholesterol, according to the company. Bergamonte is produced using patented extraction technology.
Earlier this year, HP Ingredients was also awarded an NPN product license #80067049 for LJ100 capsules, 100 mg, with four approved health claims.
Further, the following claims are now allowed to be made for Canadian Bergamonte products (500 mg):
- Helps maintain/ support healthy (total, LDL-,HDL-,) cholesterol levels.
- Helps maintain/support cardiovascular health.
- Provides antioxidants.
BERGAMONTE BPF contains bioactive compounds of extract of the juice and albedo of citrus bergamia risso, standardized to > 30% polyphenolic flavonoids consisting of Naringin, Neohesperidin, Neoeriocitrin, 1% Melitidine, and 2% Brutelidine. These flavonoids are clinically proven to help maintain healthy cholesterol levels, healthy blood glucose level, and increase HDL-cholesterol, according to the company. Bergamonte is produced using patented extraction technology.
Earlier this year, HP Ingredients was also awarded an NPN product license #80067049 for LJ100 capsules, 100 mg, with four approved health claims.
